Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents

Acta Biomaterialia

Volumn 9, Issue 5, 2013, Pages 6421-6430

  Ruiz, A ^a,b,c   Salas, G ^a,d   Calero, M ^e   Hernandez Y ^f   Villanueva, A ^e   Herranz, F ^g   Veintemillas Verdaguer, S ^a   Martinez E ^f   Barber, D F ^b   Morales, M P ^a  

^a INSTITUTO DE CIENCIA DE MATERIALES DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c San Antonio de Los Baños   (Cuba)

^d INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN NANOCIENCIA IMDEA NANOCIENCIA   (Spain)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^g CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Biomedical applications; Iron oxide; Magnetic nanoparticles; MRI contrast agents; PEG coated nanoparticles

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELL CULTURE; CHAINS; COATINGS; COORDINATION REACTIONS; DECOMPOSITION; LANTHANUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; MAGNETITE; MAGNETITE NANOPARTICLES; MOLECULES; NANOMAGNETICS; SUSPENSIONS (FLUIDS); SYNTHESIS (CHEMICAL);

BIOMEDICAL APPLICATIONS; COATED NANOPARTICLES; COORDINATION COMPLEX; LONG CIRCULATING; MRI CONTRAST AGENTS; NANOPARTICLE SURFACE; POLYETHYLENE GLYCOL-COATED NANOPARTICLE; PROPERTY; RELAXIVITY; SHORTER CHAINS;

MEDICAL APPLICATIONS;

FERUCARBOTRAN; MACROGOL; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; COVALENT BOND; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; HUMAN; HUMAN CELL; HYDRODYNAMICS; INTERNALIZATION; IONIC STRENGTH; MAGNETISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; RAT; REACTION TIME; STEREOSPECIFICITY; SURFACE CHARGE; WEIGHT REDUCTION;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84879884395     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.12.032     Document Type: Article

References (50)

1. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat Nanotechnol 2 2007 751 760
2. M. Colombo Biological applications of magnetic nanoparticles Chem Soc Rev 41 2012 4306 4334
3. J. Gao Ch. Kumar, Biofunctionalization of nanomaterials 2005 Wiley-VCH Verlag Weinheim [chapter 3]
4. S. Laurent Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem Rev 108 2008 2064 2110
5. E. Allard, C. Passirani, and J.P. Benoit Convection-enhanced delivery of nanocarriers for the treatment of brain tumors Biomaterials 30 2009 2302 2318
6. N. Kohler, G. Fryxell, and M. Zhang A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents J Am Chem Soc 126 2004 7206 7211
7. F. Re, R. Moresco, and M. Masserini Nanoparticles for neuroimaging J Phys D Appl Phys 45 2012 073001
8. U. Wattendorf, and H. Merkle PEGylation as a tool for the biomedical engineering of surface modified microparticles J Pharm Sci 11 2008 4655 4669
9. S. Perrault, C. Walkey, T. Jennings, H. Fischer, and W. Chan Mediating tumor targeting efficiency of nanoparticles through design Nano Lett 9 2009 1909 1915
10. Y. Ikeda, and Y. Nagasaki PEGylation technology in nanomedicine Adv Polym Sci 247 2012 115 140
11. Y.J. Chen, J. Tao, F. Xiong, J.B. Zhu, N. Gu, and K.K. Geng Characterization and in vitro cellular uptake of PEG coated iron oxide nanoparticles as MRI contrast agent Pharmazie 65 2010 481 486
12. M. Yallapu, S. Foy, T. Jain, and V. Labhasetwar PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications Pharm Res 27 2010 2283 2295
13. J. Zhang, S. Rana, R.S. Srivastava, and R.D.K. Misra On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles Acta Biomater 4 1 2008 40 48
14. J. Amici, E. Celasco, P. Allia, P. Tiberto, and M. Sangermano Poly(ethyleneglycol)-coated magnetite nanoparticles: preparation and characterization Macromol Chem Phys 212 2011 411 416
15. M. Kumagai Iron hydroxide nanoparticles coated with poly(ethyleneglycol)- poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging Colloid Surf (B) 56 2007 174 181
16. N. Nakajima, and Y. Ikada Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media Bioconjug Chem 6 1995 123 130
17. M. Lattuada, and T. Hatton Functionalization of monodisperse magnetic nanoparticles Langmuir 23 2007 2158 2168
18. L. Maurizi, H. Bisht, F. Bouyer, and N. Millot Easy route to functionalize iron oxide nanoparticles via long-term stable thiol groups Langmuir 25 16 2009 8857 8859
19. C. Sun, R. Sze, and M. Zhang Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI J Biomed Mater Res 78 A 2006 550 557
20. N. Kohler, C. Sun, A. Fichtenholtz, J. Gunn, C. Fang, and M. Zhang Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery Small 2 2006 785 792
21. C. Sun PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo ACS Nano 4 2010 2402 2410
22. M. Yoo Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging Acta Biomater 8 8 2012 3005 3013
23. C. Yue-Jian Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent Drug Dev Ind Pharm 36 2010 1235 1244
24. A. Aronis, Z. Madar, and O. Tirosh Lipotoxic effects of triacylglycerols in J774.2 macrophages Nutrition 24 2008 167 176
25. 4 nanoparticles for reduced non-specific uptake by macrophage cells Adv Mater 19 2007 3163 3166
26. E. Amstad, T. Gillich, I. Bilecka, M. Textor, and E. Reimhult Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups Nano Lett 9 2009 4042 4048
27. C. Fang, N. Bhattarai, C. Sun, and M. Zhang Functionalized nanoparticles with long-term stability in biological media Small 5 14 2009 1637 1641
28. L. Carr, A. Tucker, and R. Fernandez-Botran In vivo administration of l-dopa or dopamine decreases the number of splenic IFNγ-producing cells J Neuroimmunol 137 2003 87 93
29. Wahajuddin, and S. Arora Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers Int J Nanomedicine 7 2012 3445 3471
30. 4 (M = Fe, Co, Mn) nanoparticles J Am Chem Soc 126 2004 273 279
31. A.G. Roca, S. Veintemillas-Verdaguer, M. Port, C. Robic, C.J. Serna, and M.P. Morales Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles J Phys Chem (B) 113 2009 7033 7039
32. A.G. Roca, M.P. Morales, K. O'Grady, and C.J. Serna Structural and magnetic properties of uniform magnetite nanoparticles prepared by high temperature decomposition of organic precursors Nanotechnology 17 2006 2783 2788
33. X. Batlle Magnetic nanoparticles with bulk like properties (invited) J Appl Phys 109 2011 07B524
34. 2H) functionalized ferrimagnetic iron oxide nanoparticles for potential bio-applications J Mater Chem 14 2004 2781 2786
35. A.G. Roca, J.F. Marco, M.P. Morales, and C.J. Serna Effect of nature and particle size on properties of uniform magnetite and maghemite nanoparticles J Phys Chem 111 2007 18577 18584
36. C. Barrera, A. Herrera, and C. Rinaldi Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol) J Colloid Interf Sci 329 2009 107 113
37. Berenbaum MB, Gilleo KB, Evans FE. (Allied Chemical Corp.), US Patent US3943100; 1976.
38. Y. Liu, M. Shipton, J. Ryan, E. Kaufman, S. Franzen, and D. Feldheim Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers Anal Chem 79 2007 2221 2229
39. E. Fuguet, C. R'afols, M. Rosés, and E. Bosch Critical micelle concentration of surfactants in aqueous buffered and unbuffered systems Anal Chim Acta 548 2005 95 100
40. A. Villanueva The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells Nanotechnology 20 2009 115103 115112
41. H. Bin, I. Song, and T. Hyeon Inorganic nanoparticles for MRI contrast agents Adv Mater 21 2009 2133 2148
42. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell Mol Life Sci 66 2009 2873 2896
43. M. Mahmoudi, H. Hofmann, B. Rothen-Rutishauser, and A. Petri-Fink Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles Chem Rev 112 4 2012 2323 2338
44. T.J. Brunner In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility Environ Sci Technol 40 2006 4374 4381
45. Y. Huh In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals J Am Chem Soc 127 2005 12387 12391
46. A.E. Merbach, and E. Toth The chemistry of contrast agents in medical magnetic resonance imaging 2001 Wiley New York
47. H. Amiri Magnetic and relaxation properties of multifunctional polymer-based nanostructured bioferrofluids as MRI contrast agents Magn Reson Med 66 2011 1715 1721
48. R. Mejías Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy Biomaterials 32 2011 2938 2952
49. H.L. Maa, Y.F. Xub, X.R. Qia, Y. Maitanic, and T. Nagai Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers Int J Pharm 354 2008 217 226
50. Y.X. Wang, S.M. Hussain, and G.P. Krestin Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging Eur Radiol 11 2001 2319 2331